Adenocarcinoma of Lung Metastatic to Brain

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Adenocarcinoma of Lung Metastatic to Brain trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 3

NCT06500455

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to…

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patie…

United States269 participantsStarted 2024-12-12

Treatment: Computed Tomography, Fractionated Stereotactic Radiation Therapy

RecruitingNot Applicable

NCT06056115

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Brain metastasis of lung cancer is one of the most important metastasis pathways in patients with life-threatening diseases. This study explore the efficacy and…

China20 participantsStarted 2023-05-01

Treatment: Tislelizumab,Platinum

All recent trials (32 shown)

TerminatedPhase 1/2

NCT04789668

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

This phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the…

United States8 participantsStarted 2021-01-15

Treatment: Bintrafusp Alfa, Pimasertib

Active — Not RecruitingPhase 2

NCT02568267

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C),…

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2…

United States534 participantsStarted 2015-11-19

Treatment: Entrectinib

Adenocarcinoma of Lung Metastatic to Brain

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to…

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

All recent trials (32 shown)

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C),…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to…

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

All recent trials (32 shown)

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C),…

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patient…

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Posit…

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership…

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

E-MOSAIC Electronic Tool to Monitor Symptoms

Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Canc…

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer